Triple-negative breast cancer survivor sees only benefits from immunotherapy clinical trial
Lori Shults didn’t know much about clinical trials when she first came to MD Anderson in May 2017. “I thought they involved some people getting medicine and others just getting sugar pills,” she recalls. “That sounded too risky for me, so I wasn’t interested.”
Fortunately, the Hill Country school teacher soon learned that her understanding of clinical trials was both limited and inaccurate. She also learned that an innovative clinical...
Warriors within our ranks: Military veterans at MD Anderson
Leadership. Dependability. Teamwork. Problem-solving. These attributes essential for U.S. service members also are highly sought after by...
Can immunotherapy treat glioblastoma? Understanding the latest study
A new study has revived hope for the role of immunotherapy in treating glioblastoma, the most aggressive and deadly form of brain cancer in...
5 things I learned after my breast cancer diagnosis
When I was diagnosed with breast cancer in February 2017, I was so stunned initially that I felt paralyzed. I didn’t know what to do, where to go or who to call first.
Thankfully, the momentary sensation of panic passed, and since then, I’ve learned a few things.
Here are five of them.
1. Choose the breast cancer experts
I didn’t have any breast cancer symptoms prior to being diagnosed. I only learned...
The unexpected benefit of being a myCancerConnection volunteer
When I was diagnosed with metastatic melanoma in 2007, I decided to be an active participant in my cancer care. I joined a clinical trial...
Training employees to take big ideas to market
MD Anderson’s employees are full of ideas -- ideas about new ways to treat cancer, new ways to improve patient care, new ways to reduce preparation...
Hereditary leukemia syndromes: What patients and their families should know
Certain genetic changes, or mutations, can increase a person’s chances of developing cancer. These changes, known as hereditary cancer syndromes...
Ovarian cancer survivor: I found hope at MD Anderson
If it wasn’t for my daughter’s dog, I might never have found out that I had ovarian cancer. And if it wasn’t for MD Anderson, I might not...
Stage III triple-negative breast cancer survivor: How I handled treatment side effects
After being diagnosed with stage III triple-negative breast cancer in the summer of 2017, I was treated at MD Anderson with a combination...
Small cell ovarian cancer survivor grateful for life and new beginnings
At 26, small cell ovarian cancer was the last thing on Tabby Soignier’s mind. She wasn’t familiar with ovarian cancer symptoms, but she knew...
Q&A: Understanding our Immunotherapy platform
MD Anderson’s Moon Shots Program™ increases the speed at which our experts turn their research into new cancer treatment options for patients...
Survivor: Anyone with lungs can get lung cancer
Cancer does not run in my family, so when I was diagnosed with stage IV lung cancer in September 2016, it came as a complete shock. I was...